secwatch.observer — SEC 8-K summary
======================================

Issuer:     Aquestive Therapeutics, Inc. (AQST)
CIK:        0001398733
Form:       8-K
Filed at:   2024-10-16T23:59:59+00:00
Accession:  0001628280-24-042948
Event type: other
Sentiment:  neutral
Materiality: 0.05
Item codes: 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Aquestive amends bylaws: shortens nomination look-back to 2 years, updates terminology
--------------------------------------------------------------------------------

- Stockholder nomination look-back period shortened from three years to two years.
- All references to 'chairman' replaced with 'chair' for modernization.
- Amendments approved by Board and effective immediately on October 16, 2024.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1398733/000162828024042948/0001628280-24-042948-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1398733/000162828024042948/aqst-20241016.htm
  HTML page:      https://secwatch.observer/filing/0001628280-24-042948

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer